PRF Technologies receives FDA clearance for OcuRing-K phase 2 trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to PRF Technologies receives FDA clearance for OcuRing-K phase 2 trial
(NASDAQ: PRFX) Delayed: 1.60 -0.05 (3.03%)
Previous Close $1.65    52 Week High $ 
Open $1.61    52 Week Low $ 
Day High $1.84    P/E N/A 
Day Low $1.57    EPS $ 
Volume 576,472